Key statistics
On Tuesday, Kronos Bio Inc (KRON:NSQ) closed at 0.9399, 36.22% above the 52 week low of 0.69 set on May 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.98 |
---|---|
High | 0.98 |
Low | 0.852 |
Bid | 0.9003 |
Offer | 0.992 |
Previous close | 0.99 |
Average volume | 74.24k |
---|---|
Shares outstanding | 60.29m |
Free float | 44.07m |
P/E (TTM) | -- |
Market cap | 59.69m USD |
EPS (TTM) | -1.75 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease
- Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
- Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer
- Kronos Bio Announces Participation in Medical and Investor Conferences in September
- Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update
- Kronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer
- Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events
- Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer
- Kronos Bio Reports First-Quarter 2024 Financial Results
More ▼